Literature DB >> 29737419

Langerhans cell histiocytosis presenting as Crohn's disease: a case report.

Amelie Therrien1, Zaki El Haffaf2, Claire Wartelle-Bladou3, Justin Côté-Daigneault4, Bich N Nguyen5.   

Abstract

PURPOSE: We describe an exceptional case of Langerhans cell histiocytosis (LCH) that presented as Crohn's disease and primary sclerosing cholangitis.
METHODS: The patient's clinical, endoscopic, and histologic data from the Centre Hospitalier de l'Universite de Montreal were reviewed, as well as the literature on LCH involving the digestive tract and the liver, with a focus on the similarities with Crohn's disease and primary sclerosing cholangitis.
RESULTS: A 39 years-old man first presented with anal fissures and deep punctiform colonic ulcers. Histologic assessment of colon biopsies showed chronic active colitis, consistent with Crohn's disease. Mild cholestasis and endoscopic retrograde cholangiopancreatography (ERCP) showing multiple intra and extrahepatic biliary tract strictures also led to a diagnosis of sclerosing cholangitis. Perianal disease progressed despite conventional treatment with antibiotics and infliximab. Subsequent discovery of non-Langerhans cutaneous xanthogranulomas and panhypopituitarism raised the suspicion of LCH, and a second review of colon biopsies ultimately led to the diagnosis, with the identification of Langerhans cells depicting elongated, irregular nuclei with nuclear grooves as well as immunohistochemical reactivity for S100, CD1a and vimentin. BRAF V600E mutation was detected afterwards by DNA sequencing of a bile duct sample.
CONCLUSION: LCH may mimic inflammatory bowel disease (IBD) and must be suspected in the presence of other suggestive clinical signs, or when there is failure of conventional IBD treatment.

Entities:  

Keywords:  Biliary tract; Colon; Crohn’s disease; Langerhans cell histiocytosis; Primary sclerosing cholangitis

Mesh:

Year:  2018        PMID: 29737419     DOI: 10.1007/s00384-018-3066-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  12 in total

1.  Is it always Crohn's disease in a patient with perianal fistulae and skip lesions in the colon?

Authors:  Elke Roeb; Benjamin Etschmann; Stefan Gattenlöhner
Journal:  Gastroenterology       Date:  2012-05-26       Impact factor: 22.682

2.  Malignant histiocytosis of the intestine simulating Crohn's disease. Report of a case.

Authors:  Y Sakanoue; M Kusunoki; Y Shoji; H Yanagi; T Nishigami; T Yamamura; J Utsunomiya
Journal:  Dis Colon Rectum       Date:  1992-03       Impact factor: 4.585

3.  Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis.

Authors:  Sébastien Héritier; Mathilde Jehanne; Guy Leverger; Jean-François Emile; Jean-Claude Alvarez; Julien Haroche; Jean Donadieu
Journal:  JAMA Oncol       Date:  2015-09       Impact factor: 31.777

Review 4.  Langerhans cell histiocytosis involving the gastrointestinal tract.

Authors:  Amir Behdad; Scott R Owens
Journal:  Arch Pathol Lab Med       Date:  2014-10       Impact factor: 5.534

5.  [Langerhans cell histiocytosis in an adult patient associated with sclerosing cholangitis and cerebellar atrophy].

Authors:  Jérôme Desrame; Dominique Béchade; Gilles Defuentes; Pascal Goasdoue; Jean-Jacques Raynaud; Valère Claude; Jean-Luc Renard; Thierry Genereau; Gilles Coutant; Jean-Pierre Algayres
Journal:  Gastroenterol Clin Biol       Date:  2005-03

6.  Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic.

Authors:  Joshua O Podjasek; Conor G Loftus; Thomas C Smyrk; Carilyn N Wieland
Journal:  Int J Dermatol       Date:  2013-04-28       Impact factor: 2.736

7.  Gastrointestinal tract langerhans cell histiocytosis: A clinicopathologic study of 12 patients.

Authors:  Aatur D Singhi; Elizabeth A Montgomery
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

Review 8.  Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.

Authors:  Marie-Luise Berres; Carl E Allen; Miriam Merad
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

9.  Langerhans' cell histiocytosis of the liver in adults.

Authors:  Meya Abdallah; Thierry Généreau; Jean Donadieu; Jean-François Emile; Olivier Chazouillères; Cécile Gaujoux-Viala; Jean Cabane
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-05-06       Impact factor: 2.947

10.  European consensus on the histopathology of inflammatory bowel disease.

Authors:  F Magro; C Langner; A Driessen; A Ensari; K Geboes; G J Mantzaris; V Villanacci; G Becheanu; P Borralho Nunes; G Cathomas; W Fries; A Jouret-Mourin; C Mescoli; G de Petris; C A Rubio; N A Shepherd; M Vieth; R Eliakim
Journal:  J Crohns Colitis       Date:  2013-07-17       Impact factor: 9.071

View more
  1 in total

1.  Patients with both Langerhans cell histiocytosis and Crohn's disease highlight a common role of interleukin-23.

Authors:  Egle Kvedaraite; Magda Lourda; HongYa Han; Bianca Tesi; Jenée Mitchell; Maja Ideström; Natalia Mouratidou; George Rassidakis; Tatiana von Bahr Greenwood; Fleur Cohen-Aubart; Martin Jädersten; Selma Olsson Åkefeldt; Mattias Svensson; George Kannourakis; Yenan T Bryceson; Julien Haroche; Jan-Inge Henter
Journal:  Acta Paediatr       Date:  2020-10-08       Impact factor: 2.299

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.